Oric Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

ORIC Pharmaceuticals

15/08/2022 13:00

* Oric Pharmaceuticals Inc  ORIC.OQ  reported a quarterly
adjusted
loss of 51 cents​​ per share for the quarter ended in June. The
mean expectation of seven analysts for the quarter was for a
loss of 60 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Oric Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 51 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Oric Pharmaceuticals Inc shares had risen by 8.0% this
quarter and lost 67.1% so far this year.
    * The company reported a quarterly loss of $20.29 million.
    * Wall Street's median 12-month price target for Oric
Pharmaceuticals Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 12:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.60          -0.51          Beat
 Mar. 31 2022      -0.57          -0.59          Missed
 Dec. 31 2021      -0.57          -0.58          Missed
 Sep. 30 2021      -0.58          -0.47          Beat